Security key
75629V104
RECURSION PHARMACEUTICALS, INC. - Class A Stock (RXRX)
CUSIP: 75629V104
Q2 2023 13F Holders as of 30 Jun 2023
- Security type / class
- Equity / Class A Stock
- Total 13F shares
- 127,547,789
- Total 13F value
- $952,749,699
- Share change
- +1,393,964
- Put/Call ratio
- 96%
- SEC-reported price per share
- $7.47
- Number of holders
- 155
- Value change
- +$12,757,431
- Number of buys
- 81
- Number of sells
- 69
- Shares outstanding
- 525,302,736
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2023
Institutions
155
Top holders
10
RXRX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2023
Previous quarter: Q1 2023
RECURSION PHARMACEUTICALS, INC. SEC filings
RECURSION PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75629V104
Recent filing periods:
Ownership snapshot
Top reported holders of RXRX - RECURSION PHARMACEUTICALS, INC. - Class A Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VIKING GLOBAL INVESTORS LP
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
15/15
Latest evidence
31 Mar 2023
13F
Lead comparable stake: 28%
Showing 1-6 of 15 holder rows.
Quick read
VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 28%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VIKING GLOBAL INVESTORS LP's linked filing trail.
Comparable ownership
Top 5
VIKING GLOBAL INVESTORS LP
28%
Anchorage Capital Group, L.L.C.
13%
GENERAL ATLANTIC, L.P.
6.2%
SB INVESTMENT ADVISERS (UK) LTD
4.7%
MIC Capital Management UK LLP
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
28%
|
$190,303,218
143,085,126 shares
|
— | 31 Mar 2023 |
| Anchorage Capital Group, L.L.C. |
13F
Company
|
13%
|
$92,906,609
69,854,593 shares
|
— | 31 Mar 2023 |
| GENERAL ATLANTIC, L.P. |
13F
Company
|
6.2%
|
$42,985,462
32,319,896 shares
|
— | 31 Mar 2023 |
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
4.7%
|
$32,490,824
24,429,191 shares
|
— | 31 Mar 2023 |
| MIC Capital Management UK LLP |
13F
Company
|
1.6%
|
$56,373,229
8,451,758 shares
|
— | 31 Mar 2023 |
| Kinnevik AB (publ) |
13F
Company
|
1.5%
|
$51,045,917
7,653,061 shares
|
— | 31 Mar 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
155
Shares
127,547,789
Rows available
155
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
157
Q2 2023 holders
155
Holder diff
-2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 value | Q2 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend